You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
AstraZeneca
Merck
Harvard Business School
Express Scripts

Last Updated: October 1, 2023

Investigational Drug Information for Huperzine-A


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Huperzine-A?

Huperzine-A is an investigational drug.

There have been 13 clinical trials for Huperzine-A. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.

The most common disease conditions in clinical trials are Cognitive Dysfunction, Alzheimer Disease, and Hemorrhage. The leading clinical trial sponsors are U.S. Army Medical Research and Materiel Command, Yale University, and Shandong Luye Pharmaceutical Co., Ltd.

Recent Clinical Trials for Huperzine-A
TitleSponsorPhase
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot StudySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot StudyWanbangde Pharmaceutical Group Co., LTDPhase 4
A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac SurgerySecond Affiliated Hospital of Wenzhou Medical UniversityN/A

See all Huperzine-A clinical trials

Clinical Trial Summary for Huperzine-A

Top disease conditions for Huperzine-A
Top clinical trial sponsors for Huperzine-A

See all Huperzine-A clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
AstraZeneca
Merck
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.